The Cost of Quitting: GLP-1 Total Spend Data for Patients Who Stop at Month 3

Updated July 17, 2026

One in three GLP-1 patients discontinues treatment within the first 90 days. They have paid for three months of medication, three months of consultations, and in many cases a non-refundable enrollment fee. What does that early exit actually cost — and what do patients walk away with?

Why Patients Quit at Month 3

The 90-day dropout rate in GLP-1 treatment is well-documented across both brand-name and compounded medication. The primary reasons patients cite for stopping include:

Side effects. Nausea, constipation, and gastrointestinal discomfort are common during the titration phase (months 1 through 3). Some patients tolerate these effects knowing they typically diminish; others find them severe enough to abandon treatment.

Insufficient results. Weight loss during the first 3 months is often modest — 5 to 10 pounds — because the patient is still on lower titration doses. Patients expecting rapid, dramatic results may feel the medication is not working and discontinue before reaching therapeutic doses.

Cost pressure. After the introductory pricing period ends (typically month 1 or 2), the ongoing rate kicks in. A patient who enrolled at $79 per month and faces $299 per month starting in month 2 may decide the cost is unsustainable.

Lifestyle incompatibility. GLP-1 medications suppress appetite and can change food preferences. Some patients find these changes disruptive to their social life, family meals, or cultural relationship with food and choose to stop.

Total Spend at Month 3: By Provider

The 3-month total ranges from under $300 (Trimi annual plan, MadeMed oral) to nearly $950 (Telos Rx on a month-to-month high-dose path). The average across our provider list is approximately $500 to $700 for three months of compounded semaglutide.

What You Keep When You Quit

Medical records. Your telehealth provider is required to maintain your medical records and provide them upon request. These include your consultation notes, prescribed dosages, and any lab results. This documentation is useful if you restart treatment later with a different provider.

Unused medication. If you have remaining medication in a multi-dose vial, you can continue using it through the beyond-use date. A 4-week vial received mid-month still contains your paid-for medication even after you cancel the subscription. However, you should not use medication beyond its labeled beyond-use date.

Clinical knowledge. Three months of treatment provides data about how your body responds to GLP-1 medication — your tolerance level, side effect profile, and dosing response. This information is valuable if you restart treatment in the future, even with a different provider.

Weight loss (possibly). If you lost weight during the first 3 months, that weight loss is real — but studies consistently show that most patients regain weight within 6 to 12 months of discontinuing GLP-1 treatment. The cost of quitting at month 3 may include not just the $500 to $700 already spent, but also the opportunity cost of the weight regain that typically follows.

The Refund Landscape

Refund policies vary significantly, but most compounded GLP-1 providers offer limited or no refunds for voluntary discontinuation:

Most common: No refund for months already billed. If you cancel mid-month, you receive your current month's supply but are not refunded for that month.

Some providers: Prorated refund on annual plans if you cancel within the first 30 days. After 30 days, the full plan term is owed.

Medical exception: Most providers will refund patients who are medically disqualified by the prescribing provider. This is a clinical decision, not a consumer satisfaction policy.

Chargeback rights: If a provider fails to deliver medication you paid for, credit card chargeback protections apply. For voluntary cancellation, chargebacks are generally not available. We covered this topic in detail in our chargeback rights guide.

Strategies to Reduce the Cost of Early Exit

Start month-to-month. If you are uncertain whether you will tolerate the medication, do not lock into an annual plan. The per-month cost is higher, but your total financial exposure at month 3 is lower because you can cancel without ongoing obligations.

Choose low-intro providers deliberately. If a provider offers a $49 first month, take it — but understand that the purpose of intro pricing is to reduce your barrier to entry, not to represent your ongoing cost. Budget based on the month-2-and-beyond rate.

Ask about satisfaction guarantees. A small number of providers offer modified satisfaction guarantees — not full refunds, but options like dose adjustment, medication switches, or extended trial periods at reduced rates. Ask about these before enrolling.

Set a 3-month evaluation point. Before you start, decide what "success" looks like at month 3. If your criteria involve specific weight loss targets, discuss realistic expectations with your provider during the first consultation. Unrealistic expectations are a leading cause of early discontinuation.

Methodology: Discontinuation rates reflect published clinical data on GLP-1 adherence. Three-month cost calculations use current verified pricing as of July 17, 2026. Refund policies summarized from provider terms of service; specific refund availability depends on individual provider policies and circumstances. Confirm refund terms before enrolling.